Foresite Capital Management Vi LLC Centessa Pharmaceuticals PLC Transaction History
Foresite Capital Management Vi LLC
- $259 Billion
- Q3 2025
A detailed history of Foresite Capital Management Vi LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 1,314,019 shares of CNTA stock, worth $36.3 Million. This represents 12.31% of its overall portfolio holdings.
Number of Shares
1,314,019
Previous 1,253,379
4.84%
Holding current value
$36.3 Million
Previous $16.5 Billion
93.48%
% of portfolio
12.31%
Previous 9.26%
Shares
2 transactions
Others Institutions Holding CNTA
# of Institutions
139Shares Held
125MCall Options Held
1.49MPut Options Held
787K-
Medicxi Ventures Management (Jersey) LTD20MShares$551 Million73.31% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.8MShares$298 Million3.58% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10MShares$277 Million0.41% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$275 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$267 Million8.3% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...